RNA allosteric ribozyme-CRISPR / Cas sensor for small molecule substance detection and application of RNA allosteric ribozyme-CRISPR / Cas sensor

By combining RNA allosteric ribozyme with CRISPR/Cas detection system, the small molecule substance detection process is simplified, the problem of cumbersome and high cost in the existing technology is solved, and the rapid and economical detection effect is achieved.

CN118979097AActive Publication Date: 2024-11-19XIANGFU LABORATORY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411109431.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-13
Publication Date
2024-11-19
Estimated Expiration
2044-08-13

AI Technical Summary

Technical Problem

The existing nucleic acid detection technology has cumbersome steps and consumes a lot of manpower and material resources. Especially in the detection of small molecule substances, a variety of detection instruments and nucleic acid amplification methods are required, resulting in complex and high cost of detection.

Method used

The modified RNA allosteric ribozyme is used to bind to the CRISPR/Cas detection system, and the 5' end of the RNA allosteric ribozyme is transformed into the crRNA sequence of the CRISPR/Cas protein, and bind to the CRISPR/Cas protein, recognition templates and reporter molecules. Realize the detection of target small molecule substances and simplify the detection process.

Benefits of technology

It realizes rapid detection of small-molecule substances, reduces dependence on large-scale instruments and equipment, is suitable for grassroots and high-throughput detection, and has qualitative and quantitative detection capabilities, reducing detection costs and manpower and material consumption.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979097A_ABST
    Figure CN118979097A_ABST
Patent Text Reader

Abstract

The invention discloses an RNA (Ribonucleic Acid) allosteric ribozyme-CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) / Cas (Clustered Regularly Interspaced Short Palindromic Repeats) sensor for detecting small molecular substances and application of the RNA allosteric ribozyme-CRISPR / Cas sensor. The sensor comprises a modified RNA allosteric ribozyme and The modified RNA allosteric ribozyme is obtained by modifying the 5'end of RNA allosteric ribozyme capable of sensing a target small molecule substance into a crRNA sequence of CRISPR / Cas protein; the CRISPR / Cas detection system comprises a CRISPR / Cas protein, a recognition template and a reporter molecule; according to the method, the modified RNA allosteric ribozyme is induced with a target small molecule substance, and then an induction product is added into a CRISPR / Cas detection system, so that high-throughput detection on the target small molecule substance can be realized. According to the method provided by the invention, large-scale equipment is not needed, the detection time is short, and the method is suitable for base layer detection and high-throughput detection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of biochemistry and molecular biology, and in particular relates to an RNA allosteric ribozyme-CRISPR / Cas sensor for detecting small molecules and an application thereof. Background Art

[0002] Functional nucleic acids (FNAs) refer to nucleic acids with specific functions and structures, and are often used in the development of nucleic acid biosensors. RNA allosteric ribozymes are a type of functional nucleic acid, which are composed of aptamers and ribozymes. RNA allosteric ribozymes are essentially oligonucleotides that have both the specificity and affinity of aptamers for binding to target substances and the catalytic activity of ribozymes or deoxyribozymes. Allosteric ribozymes can be artificially designed and modified and applied to the development of nucleic acid biosensors to detect small molecule target effectors, such as ATP (adenine nucleoside triphosphate), TPP (thiaminepyrophosphate) and FMN (flavin mononucleotide).

[0003] When allosteric ribozymes sense small molecule target effectors, they usually self-cleave to produce small fragments of nucleic acids, which can be detected by molecular biological methods. In recent years, the CRISPR / Cas system has been widely used in the detection of nucleic acids, with the characteristics of high sensitivity and strong specificity. In particular, the CRISPR / Cas12 system is widely used in nucleic acid detection. However, during the detection process, it is often necessary to combine nucleic acid amplification methods to enrich the target nucleic acid first to improve the sensitivity. Therefore, a variety of detection instruments are required, which consumes a lot of manpower and material resources. Summary of the invention

[0004] The purpose of the present invention is to provide an RNA allosteric ribozyme-CRISPR / Cas sensor for small molecule substance detection and its application, so as to solve the problem that the existing nucleic acid detection technology has complicated steps and consumes a lot of manpower and material resources.

[0005] According to a first aspect of the present invention, there is provided an RNA allosteric ribozyme-CRISPR / Cas sensor for detecting small molecules, comprising: a modified RNA allosteric ribozyme and a CRISPR / Cas detection system; the modified RNA allosteric ribozyme is obtained by modifying the 5′ end of an RNA allosteric ribozyme that can sense a target small molecule into a crRNA sequence of a CRISPR / Cas protein; the CRISPR / Cas detection system comprises a CRISPR / Cas protein, a recognition template and a reporter molecule; wherein, by sensing the modified RNA allosteric ribozyme with a target small molecule and then adding the obtained sensing product to the CRISPR / Cas detection system, the detection of the target small molecule can be achieved.

[0006] The RNA allosteric ribozyme capable of sensing a target small molecule substance is composed of an aptamer and a ribozyme. The structure of the RNA allosteric ribozyme is different according to the different target small molecule substances.

[0007] The catalytic active center of the RNA allosteric ribozyme is a hammerhead ribozyme.

[0008] The CRISPR / Cas protein is a Cas12 series protein, including: LbCas12a protein, AapCas12b protein. Although the embodiment of the present invention mainly uses LbCas12a as the research object for experiment, it should be understood that in principle, all Cas12 series proteins are applicable to the present invention, such as AapCas12b, and its reaction temperature is 60-65°C.

[0009] It should also be understood that, depending on the type of CRISPR / Cas protein, the crRNA sequence on the modified RNA allosteric ribozyme is also different. For different CRISPR / Cas detection systems, different modifications can be made at the 5′ end of the RNA allosteric ribozyme. The crRNA sequences of different Cas proteins are also different. The embodiments of the present invention mainly use LbCas12a protein, so the crRNA and LbCas12a protein are used in pairs. If other Cas12 proteins are used, their crRNA sequences need to be changed accordingly.

[0010] Preferably, the recognition template is a double-stranded DNA template recognized by the CRISPR / Cas protein and crRNA complex.

[0011] Preferably, both ends of the reporter molecule are modified with a fluorescent group and a quenching group. Preferably, both ends of the reporter molecule are modified with a FAM fluorescent group and a BHQ1 quenching group, or a Cy5 fluorescent group and a BHQ2 quenching group.

[0012] It should be understood that the reporter molecule sequence 5′-TTATT-3′ selected in the embodiments of the present invention is a preferred embodiment of the LbCas12a protein. If other Cas12 proteins are used, this sequence also needs to be adjusted accordingly.

[0013] According to a preferred embodiment of the present invention, an RNA allosteric ribozyme-CRISPR / Cas sensor is provided, wherein the selected CRISPR / Cas protein is LbCas12a protein; the crRNA sequence of the LbCas12a protein is: 5′-UAAUUUCUACUAAGUGUAGAUAGUAGUAUGCAAGCCACGUA-3′; the sequence of the selected recognition template is: 5′-TTTGAGTAGTATGCAAGCCACGTA-3′; the sequence of the selected reporter molecule is: 5′-TTATT-3′.

[0014] According to the second aspect of the present invention, there is also provided an application of the RNA allosteric ribozyme-CRISPR / Cas sensor as described above in the detection of small molecules.

[0015] The application includes the application in the detection of ATP (adenine nucleoside triphosphate), TPP (thiamine pyrophosphate), c-di-GMP (cyclic diguanylate) and FMN (flavinmononucleotide).

[0016] RNA allosteric ribozyme is essentially an oligonucleotide. After self-cleavage, the small nucleic acid fragment generated is RNA. According to this characteristic of RNA allosteric ribozyme, the small RNA fragment generated by RNA allosteric ribozyme cleavage is designed as the crRNA sequence for sensing CRISPR / Cas12a, and the CRISPR / Cas detection method is combined with RNA allosteric ribozyme to establish an RNA allosteric ribozyme-CRISPR / Cas12a sensor, and applied to the high-throughput detection of actual samples.

[0017] The RNA allosteric ribozyme-CRISPR / Cas sensor for small molecule substance detection and its application provided by the present invention have the following advantages over the prior art:

[0018] 1) The RNA allosteric ribozyme is modified according to the method provided by the present invention without affecting the activity of the RNA allosteric ribozyme;

[0019] 2) According to the method provided by the present invention, no large-scale instruments or equipment are required, and small molecules can be detected in a short time, which is suitable for grassroots detection and high-throughput detection;

[0020] 3) According to the method provided by the present invention, not only qualitative detection but also quantitative detection can be achieved. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0022] Figure 1 It is a schematic diagram of the detection principle of the present invention;

[0023] Figure 2 The performance test results of the c-di-GMP allosteric ribozyme of Example 1 of the present invention;

[0024] Figure 3 The performance test results of the TPP allosteric ribozyme of Example 2 of the present invention;

[0025] Figure 4 The performance test results of the TPP allosteric ribozyme in Example 3 of the present invention in blood filtrate;

[0026] Figure 5 This is the result of detecting the TPP content in a blood sample using the TPP allosteric ribozyme-CRISPR Cas12a of Example 3 of the present invention. DETAILED DESCRIPTION

[0027] Example 1 Detection of c-di-GMP (cyclic diguanylate)

[0028] (1) Design of RNA allosteric ribozyme structure that senses c-di-GMP

[0029] c-di-GMP-sensing RNA allosteric ribozymes such as Figure 2 As shown in a, it should be understood that the RNA allosteric ribozyme is a prior art, which is obtained by transcription after extension with the following two primers. Among them, primer 1: TAATACGACTCACTATAGGCACCTGATGAGGGGTGG GCACAGGGCAAACCATTCGAAAGAGTGGGACGCAAAGCCTCCGGC CTA AACCAGAAGACATGGTAG, Primer 2: CTTAGGCACTACGTGGCTTCACC ACGTTTCGTGTAGGGGTAACCCCGCTAC CTACCATGTCTTCTGGTTTAG , the template extension system and transcription system are shown in Table 1 and Table 2, respectively.

[0030] according to Figure 1 As shown in the schematic diagram of the detection principle, firstly, the allosteric ribozyme sensing c-di-GMP needs to be transformed into Figure 2 The constructed c-di-GMP allosteric ribozyme was prepared by c-di-GMP-primer1 (TAATACGACTCACTATAGGTAATTTCTACTAAGTGTAG ATAGTAGTATGCAAGCCACGTAGTGCCTAAGGCACCTGATGAGGGG T GG GCACAGGGCAAACCATTC ) and c-di-GMP-primer2(ACCACGTTTCGTGTA GGGGTAACCCGCTACCTACCATGTCTTCTGGTTTAGGCCGGAGGCTTTG CGTCCCACTCTTTC GAATGGTTTGCCCTGTGC ) is obtained by extension, wherein the wavy part is the T7 promoter sequence, the straight part is the complementary pairing region of the two primers, and the extension conditions are shown in Table 1 (50 μL system):

[0031] Table 1 Template extension system

[0032] Extension conditions: pre-denaturation at 95°C for 1 min, 5 cycles of 95°C (10 s) → 58°C (30 s) → 72°C (30 s), and after the cycle, 72°C for 1 min.

[0033] The double-stranded DNA product after PCR extension was used as a template for transcription, and the transcription system is shown in Table 2. The reaction system was carried out at 37°C, incubated in a metal bath for 2-3h, and the transcribed RNA was purified using 8% dP AGE, and the corresponding bands were illuminated and recovered on a fluorescent plate using a handheld UV analyzer, and Crush-Soak buffer was added, shaken at 4°C overnight, 3 times the volume of anhydrous ethanol was added, and the RNA was placed in a -20°C refrigerator for 20min, centrifuged at 13000g and 4°C for 30min, and the RNA was recovered by sedimentation, and the concentration was measured by Nanodrop 2000, and stored at -20°C.

[0034] Table 2 Transcription system

[0035] (2) Cleavage reaction of RNA allosteric ribozyme sensing c-di-GMP

[0036] The cleavage reaction of RNA allosteric ribozyme sensing c-di-GMP was carried out in the following system: 50mM Tris-HCl (pH7.5), 100mM NaCl, 10mM MgCl2, 45nM RNA allosteric ribozyme. After adding 0nM, 30nM, 100nM, 300nM, 1000nM, and 3000nM, respectively, the reaction was carried out at 23°C for 3min. 8% dPAGE electrophoresis was performed, Cyber ​​gold nucleic acid dye was used for staining for 10min, and the gel imaging system was used for imaging. After gel imaging, the band intensity was quantitatively analyzed using Quantity One software to calculate the cleavage rate. The dPAGE electrophoresis diagram is shown in the figure below. Figure 2 As shown in c.

[0037] According to the cleavage rate calculated in the gel image, a logarithmic curve of the cleavage rate of the c-di-GMP allosteric ribozyme and the c-di-GMP concentration was drawn. Figure 2 As shown in Figure d, the EC50 was calculated. The EC50 value of the modified c-di-GMP allosteric ribozyme was 318.5 nM, which was equivalent to that before modification, indicating that the structural modification of the RNA allosteric ribozyme by the strategy adopted by the present invention did not affect the activity of the enzyme.

[0038] (3) CRISPR / Cas12a detection

[0039] CRISPR / Cas12a detection was performed in the following 20 μL system: 200 nM LbCas12a protein, 5 nM double-stranded detection template, 250 nM reporter molecule (5′-FAM-TTATT-BHQ1-3′), 2 μL RNA allosteric ribozyme cleavage product, 1× NEBuffer 2.1, 37°C, reaction time 30 min, and real-time fluorescence acquisition using a microplate reader (Boten, USA). The results are shown in Figure 2 As shown in Figure e, as the c-di-GMP sensing concentration increases, the fluorescence signal value increases accordingly, showing a positive correlation. From the real-time fluorescence curve, it can be concluded that CRISPR / Cas12a can detect a minimum of 30nM c-di-GMP. Based on the fluorescence value at 30 minutes of reaction, a logarithmic curve of fluorescence value and c-di-GMP concentration was drawn, and the result showed a linear relationship, as shown in Figure 5. Figure 2 As shown in f, the CRISPR / Cas12a detection results of the cleavage system of the c-di-GMP standard with known concentration can be used to draw a standard curve, and then the detection results of the cleavage system with unknown c-di-GMP concentration can be put into the standard curve to calculate the c-di-GMP concentration of the unknown system.

[0040] Example 2 Detection of TPP (thiamine pyrophosphate)

[0041] (1) Design of RNA allosteric ribozyme structure that senses TPP

[0042] RNA allosteric ribozymes that sense TPP Figure 3 It should be understood that the RNA allosteric ribozyme is a prior art, which is obtained by transcription after extension with the following two primers. Among them, the sequence of primer 3 is: TAATACGACTCACTATAGGGTATGCAAGCCACGTAGTGCCTATACCTGAT AGGTAGGCACCTGATGAGGCTCCCGGGGTGCCCT TGTGCGTCAAGGCTG AGAAATA , the sequence of primer 4 is: AGCCACGTTTCGGAGCCTCCCTACGCTGGCATTATCCAGATCAGGTGATACGGG TATTTCTCAGCCTTGACGCACA , the template extension system and transcription system are shown in Table 3 and Table 4, respectively.

[0043] according to Figure 1 The detection principle diagram shown in the figure first requires the transformation of the allosteric ribozyme that senses TPP into Figure 3 The c-di-GMP allosteric ribozyme constructed was prepared by TPP-prime r1 (TAATACGACTCACTATAGGTAATTTCTACTAAGTGTAGATAGTAGTAT GCAAGCCACGTAGTGCCTATACCTGATAG GTAGGCACCTGATGAGGCTC CCGGGGTG ) and TPP-primer2(AGCCACGTTTCGGAGCCTCCCTACGCTG GCATTATCCAGATCAGGTGATACGGGTATTTCTCAGCCTTGACGCACAAG GG CACCCCGGGAGCCTCATCAGGTGCCTAC ) was obtained by extension, and the extension conditions are shown in Table 3 (50 μL system):

[0044] Table 3 Template extension system

[0045] Extension conditions: pre-denaturation at 95°C for 1 min, 5 cycles of 95°C (10 s) → 58°C (30 s) → 72°C (30 s), and after the cycle, 72°C for 1 min.

[0046] The double-stranded DNA product after PCR extension was used as a template for transcription, and the transcription system is shown in Table 4. The reaction system was carried out at 37°C, incubated in a metal bath for 2-3h, and the transcribed RNA was purified using 8% dP AGE, and the corresponding bands were illuminated and recovered on a fluorescent plate using a handheld UV analyzer, and Crush-Soak buffer was added, shaken at 4°C overnight, 3 times the volume of anhydrous ethanol was added, and the mixture was placed in a -20°C refrigerator for 20min, centrifuged at 13000g and 4°C for 30min, and the RNA was recovered by sedimentation, and the concentration was measured by Nanodrop 2000, and stored at -20°C.

[0047] Table 4 Transcription system

[0048] (2) Cleavage reaction of RNA allosteric ribozyme sensing TPP

[0049] The cleavage reaction of the RNA allosteric ribozyme that senses TPP was carried out in the following system: 50mM Tris-HCl (pH7.5), 100mM NaCl, 10mM MgCl2, 45nM RNA allosteric ribozyme. After adding 0nM, 10nM, 25nM, 50nM, 100nM, 250nM, 500nM, and 1000nM TPP, respectively, the reaction was carried out at 23°C for 60min. 8% dPAGE electrophoresis was performed, Cyber ​​gold nucleic acid dye was used for staining for 10min, and the gel imaging system was used for imaging. After gel imaging, the band intensity was quantitatively analyzed using Quantity One software to calculate the cleavage rate. The dPAGE electrophoresis diagram is shown below. Figure 3 As shown in c.

[0050] The cleavage rate of TPP allosteric ribozyme and the logarithmic curve of TPP concentration were drawn according to the cleavage rate calculated in the gel image. Figure 3 As shown in Figure d, the EC50 was calculated. The EC50 value after the modification was 68.5 nM, which was equivalent to that before the modification, indicating that the structural modification of the RNA allosteric ribozyme by the strategy adopted by the present invention did not affect the activity of the enzyme.

[0051] (3) CRISPR / Cas12a detection

[0052] CRISPR / Cas12a detection was performed in the following 20 μL system: 200 nM LbCas12a protein, 5 nM double-stranded detection template, 250 nM reporter molecule (5′-FAM-TTATT-BHQ1-3′), 2 μL RNA allosteric ribozyme cleavage product, 1× NEBuffer 2.1, 37°C, reaction time 30 min, and real-time fluorescence acquisition using a microplate reader (Boten, USA). The results are shown in Figure 3As shown in Figure e, as the TPP sensing concentration increases, the fluorescence signal value increases accordingly, showing a positive correlation. From the real-time fluorescence curve, it can be concluded that CRISPR / Cas12a can detect TPP at a minimum of 25nM. Based on the fluorescence value at 30 minutes of reaction, a fluorescence value and TPP concentration logarithmic curve were plotted, and the result showed a linear relationship, as shown in Figure 5. Figure 3 As shown in f, the CRISPR / Cas12a detection results of the cutting system of the TPP standard with known concentration can be used to draw a standard curve, and then the detection results of the cutting system with unknown TPP concentration can be put into the standard curve to calculate the TPP concentration of the unknown system.

[0053] Example 3 Detection of TPP content in blood samples

[0054] (1) Blood sample collection

[0055] Mouse type: C57

[0056] Sampling tube type: In whole blood, thiamine pyrophosphate is mainly present in red blood cells, so when measuring TPP in blood, it is necessary to first lyse the red blood cell membrane to release thiamine pyrophosphate and make it free in the solution. Due to the presence of thrombin, blood will coagulate in vitro after collection, and the sample needs to be treated to prevent coagulation. EDTA anticoagulant blood collection tubes are commonly used anticoagulant tubes for blood collection. Generally, EDTA is excessive when used, but excessive EDTA will chelate Mg in the system. 2+ , which affects the activity of RNA aptamer enzymes that sense TPP, so heparin was used as the anticoagulant in the sampling tube.

[0057] Blood collection method: cardiac blood collection was adopted. First, mice were euthanized using carbon dioxide. Then, 0.4-0.6 mL of cardiac blood was collected from each mouse using a 1 mL syringe. The blood was placed into a vacuum blood collection tube with lithium heparin coated on the inner wall. The tube was mixed by inverting the tube upside down and placed on ice for later use.

[0058] (2) Blood sample processing:

[0059] The protein in the blood is denatured by chloroform treatment to release TPP, and the blood filtrate is obtained by filtration. The specific operation steps are as follows:

[0060] ① Pipette 150 μL of mouse whole blood from a vacuum blood collection tube coated with lithium heparin into a 1.5 mL centrifuge tube, add 300 μL of deionized water, and vortex for 10 seconds;

[0061] ② Add 750 μL of chloroform and vortex for 5 minutes to mix evenly;

[0062] ③3100 rpm, 4°C, centrifugation for 10 min;

[0063] ④ Take the upper solution (about 400 μL), centrifuge at 16000g, 4°C for 10 min to completely remove impurities;

[0064] ⑤ Take the supernatant (about 380 μL), add it to a 10 kDa ultrafiltration tube, and centrifuge at 8000 g, 4 ° C, for 30 min;

[0065] ⑥ Recover the filtrate, which is the blood filtrate sample;

[0066] ⑦ If the next experiment is to be carried out immediately, the blood filtrate sample should be placed on ice for later use; if the next experiment is to be carried out after a long time, the blood filtrate sample should be stored in a -80℃ refrigerator for later use.

[0067] (3) Removal of TPP from blood filtrate samples

[0068] During the experiment, blood filtrate without TPP is used as a matrix to study RNA aptamers that sense TPP. Heat treatment is used to remove TPP from the blood filtrate sample. The specific operation steps are as follows: the treated blood filtrate sample is heated at 98°C in a metal bath for 2 hours, and then cooled naturally to obtain the blood filtrate sample with TPP removed. After the treatment, it is stored at -20°C for later use.

[0069] (4) Establishing a standard curve

[0070] A standard curve was established using the blood filtrate sample from which TPP was removed as the matrix. The reaction was carried out in a 40 μL system: 30 μL of blood filtrate from which TPP was removed, 10 mM MgCl2, 1 mM EDTA, 45 nM TPP allosteric ribozyme, and 0 nM, 10 nM, 25 nM, 50 nM, 100 nM, 250 nM, and 500 nM TPP were added, respectively. The reaction was carried out at 23°C for 60 min. The reaction product was divided into two portions, one portion was 15 μL of the cleavage reaction product, and 15 μL of 2×dPAGE loading buffer was added to terminate the reaction. Then, 8% dPAGE electrophoresis was performed, and Cybergold nucleic acid dye was used to stain for 10 min, and imaging was performed using a gel imaging system; the other portion was 25 μL of the cleavage reaction product, which was placed on ice for subsequent detection experiments. The dPAGE gel image is shown below. Figure 4 As shown in a, the results show that in the blood filtrate sample matrix without TPP, the allosteric ribozyme sensing TPP exhibits good cleavage activity, RNA is not degraded in this system, the background signal is normal, and the cleavage efficiency increases accordingly with the increase of the induced TPP concentration, indicating that it can react well in the blood filtrate matrix.

[0071] (5) TPP allosteric ribozyme cleavage reaction in sample

[0072] The reaction was carried out in a 40μL system: 30μL blood filtrate, 10mM MgCl2, 1mM EDTA, 45nM TPP allosteric ribozyme. The reaction was carried out at 23℃ for 60min. The reaction product was divided into two parts, one part was 15μL of cleavage reaction product, 15μL 2×dPAGE loading buffer was added to terminate the reaction, and then 8% dPAGE electrophoresis was performed, stained with Cyber ​​gold nucleic acid dye for 10min, and imaged by gel imaging system; the other part was 25μL of cleavage reaction product, which was placed on ice for subsequent detection experiments. Its dPA GE gel image is shown below: Figure 5 As shown in a.

[0073] (6) CRISPR / Cas12a detection

[0074] CRISPR / Cas12a detection was performed in the following 20 μL system: 200 nM LbCas12a protein, 5 nM double-stranded detection template, 250 nM reporter molecule (5′-FAM-TTATT-BHQ1-3′), 2 μL RNA allosteric ribozyme cleavage product, 1× NEBuffer 2.1, 37°C, reaction time 30 min, and real-time fluorescence acquisition using a microplate reader (Boten, USA). The results are shown in Figure 4 As shown in Figure b, in the blood filtrate matrix, as the TPP sensing concentration increases, the fluorescence signal value increases accordingly, showing a positive correlation. From the real-time fluorescence curve, it can be concluded that CRISPR / Cas12a can detect TPP at a minimum of 25nM. Based on the fluorescence value at 30 minutes of reaction, a fluorescence value and TPP concentration logarithmic curve were plotted, and the result showed a linear relationship, as shown in Figure 2. Figure 4 As shown in c, the CRISPR / Cas12a detection results of the cutting system of the TPP standard with known concentration can be used to draw a standard curve, and then the detection results of the cutting system with unknown TPP concentration can be put into the standard curve to calculate the TPP concentration of the unknown system.

[0075] Using the above method, the TPP test results in the samples are as follows: Figure 5 As shown in b, the results show that this method can accurately measure the TPP content in the blood filtrate sample, and the measurement value is basically consistent with the HPLC detection method.

[0076] It should be understood that Example 2 is a theoretical study, and Example 3 is a test in actual samples. The above examples prove that the method of the present invention is also applicable to the detection of actual samples.

[0077] The above is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention. The above embodiments of the present invention can also be modified in various ways. All simple, equivalent changes and modifications made according to the claims and the description of the present invention fall within the scope of protection of the claims of the present invention. The contents not described in detail in the present invention are all conventional technical contents.

Claims

1. An RNA allosteric ribozyme-CRISPR / Cas sensor for detecting small molecules, characterized in that: include: A modified RNA allosteric ribozyme and CRISPR / Cas detection system; the modified RNA allosteric ribozyme is obtained by modifying the 5′ end of an RNA allosteric ribozyme that can sense a target small molecule substance into a crRNA sequence of a CRISPR / Cas protein; the CRISPR / Cas detection system includes a CRISPR / Cas protein, a recognition template and a reporter molecule; Among them, by sensing the modified RNA allosteric ribozyme with the target small molecule substance, and then adding the obtained sensing product to the CRISPR / Cas detection system, high-throughput detection of the target small molecule substance can be achieved.

2. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 1, characterized in that The RNA allosteric ribozyme capable of sensing a target small molecule substance is composed of an aptamer and a ribozyme. The structure of the RNA allosteric ribozyme is different according to the different target small molecule substances.

3. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 2, characterized in that The catalytic active center of the RNA allosteric ribozyme is a hammerhead ribozyme.

4. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 1, characterized in that The CRISPR / Cas protein is a Cas12 series protein, including: LbCas12a protein and AapCas12b protein.

5. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 1, characterized in that Depending on the type of CRISPR / Cas protein, the crRNA sequence in the modified RNA allosteric ribozyme is also different.

6. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 1, characterized in that The recognition template is a double-stranded DNA template recognized by the CRISPR / Cas protein and crRNA complex.

7. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 1, characterized in that Both ends of the reporter molecule are modified with a fluorescent group and a quenching group.

8. The RNA allosteric ribozyme-CRISPR / Cas sensor according to claim 1, characterized in that The CRISPR / Cas protein is LbCas12a protein; The crRNA sequence of the LbCas12a protein is: 5′-UAAUUUCUAAGUGUAGAUAGUAGUAUGCAAGCCACGUA-3′; The sequence of the recognition template is: 5′-TTTGAGTAGTATGCAAGCCACGTA-3′; The sequence of the reporter molecule is: 5′-TTATT-3′.

9. Use of the RNA allosteric ribozyme-CRISPR / Cas sensor as described in any one of claims 1 to 8 in the detection of small molecules.

10. The use according to claim 9, characterized in that: The application includes the application of the RNA allosteric ribozyme-CRISPR / Cas sensor in the detection of ATP, TPP, c-di-GMP and FMN.

Citation Information

Patent Citations

  • Cas12a-CcrRNA system based on regulation and control of nuclease and circular guide RNA and application of Cas12a-CcrRNA system

    CN114231530A

  • Biosensing system based on deoxyribozyme combined CRISPR / Cas12a and application thereof

    CN117844950A